W911QY20C0119 — ASTRAZENECA PHARMACEUTICALS LP — Department of Defense ($1,107,934,203)

SARS-COV-2 THERAPEUTIC AZD7442 Recipient: ASTRAZENECA PHARMACEUTICALS LP Obligated amount: $1,107,934,203 Awarding agency: Department of Defense (Department of the Army) Procurement instrument identifier (PIID): W911QY20C0119 Start date: 2020-09-30 End date: 2023-07-01

Related documents

• N0001918C1021 — RTX CORPORATION — Department of Defense ($8,688,654,907)#604302
• 75FCMC22C0037 — PALMETTO GBA, LLC — Department of Health and Human Services ($792,766,699)#655582
• N0001917C0020 — RTX CORPORATION — Department of Defense ($2,682,738,780)#604547
• 75FCMC21F0002 — PALMETTO GBA, LLC — Department of Health and Human Services ($41,311,964)#601824
• N0001918C1025 — THE BOEING COMPANY — Department of Defense ($1,129,466,004)#605031